phrykt

Neumora Therapeutics, Inc. (NMRA): who owns it and who trades it

As of Nov 16, 2026, NMRA insiders reported 15 open-market sales worth $784K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Daljit Singh Aurora (See Remarks), with $723K. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Neumora Therapeutics

From the latest filings

Overall: more selling than buying. Insiders and famous investors mostly sold. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns NMRA

112 funds and institutions reported NMRA shares worth $131M at the end of Q2 2026, about 42% of the company. The largest holder is Siren, L.L.C. with 4.7%.

Funds and institutions (13F) 42%Everyone else 58%

10 largest owners, by share of the company

Siren, L.L.C.4.7%
BlackRock, Inc.4.3%
Softbank Group Corp.3.3%
Vanguard Capital Management LLC2.6%
MIC Capital Management UK LLP2.5%
FMR LLC (Fidelity)1.9%
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST1.8%
Geode Capital Management, LLC1.4%
ICONIQ Capital, LLC1.4%
Two Sigma Investments, LP1.2%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Siren, L.L.C.8.50M4.67%$14.4MNo change
BlackRock, Inc.7.79M4.28%$13.2M+279%
Softbank Group Corp.6.09M3.35%$10.4MNo change
Vanguard Capital Management LLC4.67M2.57%$7.9M+20%
MIC Capital Management UK LLP4.46M2.45%$7.6MNo change
FMR LLC (Fidelity)3.50M1.92%$5.9MNo change
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST3.31M1.82%$5.6MNo change
Geode Capital Management, LLC2.61M1.43%$4.4M+140%
ICONIQ Capital, LLC2.56M1.41%$4.4MNo change
Two Sigma Investments, LP2.24M1.23%$3.8M+10%
Orbimed Advisors LLC2.14M1.18%$3.6M–
Lunate Capital Ltd2.12M1.17%$3.6MNo change
Boxer Capital Management, LLC2.00M1.10%$3.4M–
Johnson & Johnson1.85M1.02%$3.1MNo change
State Street Corp1.58M0.87%$2.7M+297%
Tudor Investment Corp Et Al1.36M0.74%$2.3M+76%
Ikarian Capital, LLC1.28M0.70%$2.2MNo change
Renaissance Technologies LLC1.26M0.69%$2.1M-9%
Affinity Asset Advisors, LLC1.07M0.59%$1.8M–
Marshall Wace, LLP904,4580.50%$1.5M-24%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, NMRA insiders reported $0 of open-market purchases and $784K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$784K
15 trades, 4 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Aug 21, 2026
Filed Aug 21, 2026

Purchases and sales by month

$701K$701KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 21, 2026Daljit Singh AuroraSee RemarksSale20,553$1.59$32.7KForm 4
Aug 21, 2026Daljit Singh AuroraSee RemarksSale21,055$1.60$33.7KForm 4
Aug 20, 2026Daljit Singh AuroraSee RemarksSale66,711$1.51$101KForm 4
Aug 20, 2026Daljit Singh AuroraSee RemarksSale67,741$1.51$102KForm 4
Aug 19, 2026Daljit Singh AuroraSee RemarksSale30,918$1.65$51KForm 4
Aug 19, 2026Daljit Singh AuroraSee RemarksSale31,000$1.65$51.1KForm 4
Aug 18, 2026Daljit Singh AuroraSee RemarksSale34,987$1.59$55.6KForm 4
Aug 18, 2026Daljit Singh AuroraSee RemarksSale34,162$1.58$54KForm 4
Aug 17, 2026Daljit Singh AuroraSee RemarksSale55,016$1.50$82.5KForm 4
Aug 17, 2026Daljit Singh AuroraSee RemarksSale57,670$1.51$87.1KForm 4
Aug 17, 2026Daljit Singh AuroraSee RemarksSale34,020$1.49$50.7KForm 4
Feb 17, 2026Daljit Singh AuroraSee RemarksSale6,165$3.56$21.9KForm 4
Feb 17, 2026Joshua PintoPresidentSale5,967$3.54$21.1KForm 4
Feb 17, 2026Paul L BernsDirectorSale9,819$3.51$34.5KForm 4
Feb 17, 2026Michael Lee MilliganSee RemarksSale1,436$3.57$5.1KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Daljit Singh AuroraSee Remarks–$723KAug 21, 2026
Paul L BernsSee Remarks, Director–$34.5KFeb 17, 2026
Joshua PintoPresident–$21.1KFeb 17, 2026
Michael Lee MilliganSee Remarks–$5.1KFeb 17, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

NMRA short interest

Low short interest. 3.7% of NMRA shares are sold short: about 1 share in 27. Over the last 12 reports the number of shares short went up 43%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 7.01M NMRA shares were sold short, 3.7% of the shares outstanding, up 24.2% from the report before. At the average daily volume of 1.37M shares, buying them all back would take about 5.1 trading days (days to cover).

Shares short, % of all shares

3.73%May 15Oct 304.52%

Days to cover

5.1May 15Oct 3015.2

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20267.01M3.73%+24%1.37M5.1
Oct 15, 20265.64M3.00%-16%2.43M2.3
Sep 30, 20266.69M3.56%-4%2.49M2.7
Sep 15, 20266.98M3.71%-13%773,5039.0
Aug 31, 20268.03M4.27%+0%788,84610.2
Aug 14, 20267.99M4.25%+5%596,20413.4
Jul 31, 20267.62M4.19%-2%692,47311.0
Jul 15, 20267.79M4.28%+17%1.03M7.6
Jun 30, 20266.68M3.67%+36%6.01M1.1
Jun 15, 20264.92M2.70%-12%2.26M2.2
May 29, 20265.58M3.07%+14%1.11M5.0
May 15, 20264.90M2.69%+6%1.65M3.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Neumora Therapeutics company events

Neumora Therapeutics filed 11 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership, listing). The latest was on Oct 30, 2026.

  1. Oct 30, 2026ListingNeumora Therapeutics, Inc. received written notice from The Nasdaq Stock Market LLC indicating that the Company is not in compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Global Select Market, as set forth in Listing Rule 5450(a)(1). Filing
  2. Aug 14, 2026LeadershipThe Company announced that Paul L. Berns, the Company’s current Chief Executive Officer, will become the Company’s Executive Chairperson of the Board of Directors, and Joshua Pinto, Ph.D., the Company’s current President, will succeed Mr. Berns as the Company’s Chief Executive Officer effective… Filing
  3. Jul 27, 2026AnnouncementNeumora Therapeutics, Inc. issued a press release announcing favorable pre-clinical toxicology results from NMRA-215. Filing
  4. Jun 15, 2026AgreementNeumora Therapeutics, Inc. as borrower, entered into a Third Amendment to the Loan and Security Agreement, with K2 HealthVentures LLC as a lender, and the lenders party thereto from time to time (collectively, “Lenders”, and each, a “Lender”), and K2 HealthVentures LLC, as administrative agent for… Filing
  5. May 29, 2026VoteReported shareholder vote results. Filing
  6. May 7, 2026ResultsReleased financial results. Filing
  7. Mar 30, 2026ResultsReleased financial results. Filing
  8. Feb 11, 2026AnnouncementShared information with investors. Filing
  9. Jan 12, 2026AnnouncementShared information with investors. Filing
  10. Jan 5, 2026AnnouncementNeumora Therapeutics, Inc. issued press releases announcing positive results from its Phase 1b signal-seeking study of NMRA-511 in people with Alzheimer’s disease (AD) agitation and key pipeline updates and anticipated 2026 milestones. Filing
  11. Nov 21, 2025SharesSold new shares outside a public offering. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Neumora Therapeutics financials

Famous investors that hold NMRA

4 of the 50 well-known investors we track reported holding NMRA in their latest 13F filing. The largest position is Jim Simons's, worth $674K.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Jim Simons · Renaissance TechnologiesQ3 20261.13M$674K0.0%-11%
Ken Griffin · Citadel AdvisorsQ3 20261.03M$613K0.0%+24%
Paul Tudor Jones · Tudor Investment CorpQ3 2026631,091$376K0.0%-53%
Israel Englander · Millennium ManagementQ3 2026328,544$196K0.0%-35%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named NMRA in the last 120 days.

FiledHolderFormStake
Nov 16, 2026Paul L Berns13G/A5.4%
Nov 16, 2026Paul L Berns13G/A5.4%

Questions about Neumora Therapeutics, Inc. (NMRA) stock

Who owns the most NMRA stock?

The largest reported owner of Neumora Therapeutics, Inc. (NMRA) is Siren, L.L.C., with 4.7% of the company. In total, 112 funds and institutions reported holding NMRA at the end of Q2 2026, together about 42% of the shares. See the largest owners.

Are NMRA insiders buying or selling?

In the last 12 months, NMRA insiders reported no open-market purchases and 15 sales worth $784K. The latest trade was on Aug 21, 2026. See every trade.

What is the short interest in NMRA?

As of Oct 30, 2026, 7.01M NMRA shares were sold short, 3.7% of the shares outstanding, up 24.2% from the report before. At the average daily volume of 1.37M shares, buying them all back would take about 5.1 trading days (days to cover). See the history.

Which famous investors hold NMRA?

4 of the 50 well-known investors we track reported NMRA in their latest 13F filing, including Jim Simons, Ken Griffin, Paul Tudor Jones. The largest position is worth $674K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.